North America Cosmetic Surgery Market

North America Cosmetic Surgery Market Outlook 2036

The North America Cosmetic Surgery Market was valued USD 35.0 Billion in 2025 and is projected to reach USD 82.5 Billion by 2036 at a CAGR of 8.9%. The major market growth drivers will include enhanced acceptance of cosmetic treatment procedures, growing preference towards non-invasive treatment procedures, increased influence of social media, and availability of advanced cosmetic products and injectables. Consumers are preferring aesthetic treatment procedures that have a short duration of recovery period, low risks associated with the procedure, and natural results. Factors such as strong presence of aesthetic centers, highly developed healthcare system, high disposable income levels, and presence of key players in medical aesthetics are expected to contribute towards market growth.

Market Size & Highlights

• The North America Cosmetic Surgery Market reached USD 35.0 Billion in 2025.
• The market is expected to reach USD 82.5 Billion by 2036.
• The North America cosmetic surgery industry is anticipated to expand at a CAGR of 8.9% from 2026 to 2036.
• Major companies in the North America cosmetic surgery industry include AbbVie Inc., Galderma Group AG, Merz Pharma GmbH & Co. KGaA, Bausch Health Companies Inc., and InMode Ltd.
• By Country, the United States dominated the market in 2025, holding a revenue share of 82.0%.
• By Procedure Type, Non-surgical Cosmetic Procedures dominated the market in 2025, holding a revenue share of 58.0%.

Analysts’ Viewpoint on the North America Cosmetic Surgery Market

The North America Cosmetic Surgery Market is anticipated to grow strongly due to increasing demand from consumers for beauty enhancement, face rejuvenation, body contouring, and anti-aging solutions. There is an increased acceptance of aesthetic surgeries amongst people belonging to various age brackets because of the patient's desire for natural results, quick recovery period, and individualized treatments. The growth of the market will be driven by the increasing adoption of medical spas, dermatology clinics, and cosmetic surgery facilities in the USA and Canada.

The most common procedure category is anticipated to continue being that of the nonsurgical cosmetic procedures since the injectables, fillers, lasers, skin tightening, and non-invasive body contouring procedures are more easily available than the surgical procedures. ISAPS reports over 20.5 million procedures of the non-surgical cosmetic procedure conducted in 2024 worldwide, compared to the over 17.4 million of the surgical procedures conducted.

The U.S. will retain its dominance in the North American market due to high consumer expenditure on aesthetics, a substantial number of providers, presence of medical aesthetics companies, and early adoption of injectables and energy-based devices. As per ISAPS, in 2024, the country had the largest number of cosmetic treatments in the world at over 6.1 million treatments.

The competition would be based around next-generation injectables, regenerative aesthetics, body shaping, laser treatment, ultrasound skin lifting, and AI-driven consultation platforms. Those with good product portfolio, solid clinical proof, brand name, and training programs for providers will get an edge over the other players during the forecast period.

North America Cosmetic Surgery Market Introduction

North America Cosmetic Surgery Market includes the use of both surgical and non-surgical aesthetic procedures performed in order to improve the physical appearance, facial features, body contour, skin condition, and aging aesthetics issues. The market includes various procedures such as liposuction, breast enhancement, nose job, blepharoplasty, face lift, abdominoplasty, injections of botulinum toxin, dermal filler injections, chemical peel, laser skin rejuvenation, skin tightening, and non-surgical body contouring. Market expansion is driven by increasing consumers' choice for less invasive and non-invasive therapies. Non-surgical treatments have been gaining significant popularity owing to faster recovery period, low-risk nature, low-cost alternative to surgery, and quicker return to normal activities.

Rising Demand for Non-surgical and Minimally Invasive Aesthetic Procedures Supports Market Growth

The increasing preference of consumers for non-invasive treatments is among the main reasons that contribute to the growth of the North America cosmetic surgery market. Consumers want procedures that will enhance their appearance without requiring hospitalization for several days and long recovery periods. These include botulinum toxin injections, dermal fillers, laser skin resurfacing, skin tightening, chemical peelings, and fat reduction.

Non-surgical treatments are preferred since they can be done in outpatient facilities, dermatological clinics and medical spas. Non-surgical treatments are appropriate for people who want their changes in an incremental and natural manner. The increasing popularity of preventive aesthetics among the youth is another factor driving demand for these products. People in their twenties, thirties and forties are increasingly relying on injectables and skin treatments for signs of early aging.

According to ISAPS, the number of non-surgical cosmetic procedures perform globally in 2024 stood at 20.5 million, while the number of surgeries done by plastic surgeons stood at 17.4 million. The report indicates that the total growth rate of cosmetic surgical and non-surgical procedures since 2020 stood at 42.5%.

In the U.S., the proportion of minimally invasive procedures remains quite high among the total number of requests for aesthetic treatments. In 2024, the number of treatments conducted using hyaluronic acid fillers is estimated at 5,331,426, while the number of treatments using non-hyaluronic acid fillers was 932,861, by the American Society of Plastic Surgeons. This is evidence that the demand for injectables in the region is high. Given that patients favor treatments that require less recovery time, non-invasive aesthetic procedures will remain important drivers for the market growth.

Increasing Procedure Volume and Wider Acceptance of Cosmetic Treatments Boosts Market Growth

An increase in procedure volume and social acceptance of aesthetic treatments are some other factors that are driving the growth of the North America Cosmetic Surgery Market. Aesthetic procedures and surgeries have no longer remained restricted to a certain consumer base. The need for such treatments is now growing among consumers belonging to various age groups, socio-economic groups, and even genders. Consumers are increasingly getting comfortable with procedures that enhance the look of their faces, bodies, skin, and appearance.

Changing beauty standards, the influence of social media, the culture of video conferencing, and the rising awareness about the latest aesthetic procedures are some other factors that are aiding the growth of the market. People nowadays want customized treatment solutions that help them achieve subtle results.

According to the American Society of Plastic Surgeons (ASPS), liposuction continued to remain in first place in terms of the frequency of its occurrence compared to other forms of plastic surgery in 2023, with 347,782 liposuctions performed, indicating an increase by 7% compared to 2022. Tummy tuck procedures grew to 170,110, representing an increase of 5% over the previous year. There were 304,181 breast augmentations carried out in 2023.

As per ISAPS, the U.S. carried out more than 6.1 million cosmetic procedures in 2024, ranking first worldwide when it comes to cosmetic procedures. The large number of procedures carried out will drive the demand for injectables, implants, body contouring equipment, lasers, and cosmetic surgical procedures. With growing popularity of cosmetic procedures, the market is expected to show steady growth in the coming years.

Regenerative Aesthetics and Advanced Energy-based Devices Create New Growth Space

The development of regenerative aesthetics along with energy-based equipment is generating new possibilities in the North America Cosmetic Surgery Market. People are searching for therapies that help to enhance skin texture, add volume, aid in collagen synthesis, and ensure natural results. These factors have paved the way for the emergence of biostimulators, regenerators, radiofrequency equipment, skin lifting systems using ultrasound technology, and lasers.

The regenerative aesthetics has been gaining popularity since it is based on enhancing the quality of the skin tissues rather than filling the lines and wrinkles. Biostimulatory injections are currently being used for the purpose of facial rejuvenation, enhancement of skin quality and body aesthetics. As reported in April 2026, Merz Aesthetics was granted FDA approval to use RADIESSE in the treatment of wrinkles in the décolleté region in individuals who are at least 22 years of age. According to the company, RADIESSE is the first and only approved product in the U.S. for regenerating the face and body.

Energy-based Devices have been making excellent opportunities for themselves since people seek out non-invasive skin-tightening, resurfacing, hair removal, fat reduction, and body contouring treatments. Devices that use lasers, radiofrequency, ultrasound, and intense pulse light are popular in dermatological clinics and medical spas today. Solta Medical introduced the Clear + Brilliant Touch laser device in Canada in February 2026 after receiving health Canada approval.

This trend will stay positive in the future because service providers are adding more procedures in their treatment menu other than surgery. The firms that provide advanced injectable devices, energy-based platforms, and clinical outcomes are likely to gain from the increasing customer demands for natural, safe, and quick cosmetic procedures.

Non-surgical Cosmetic Procedures Lead the North America Cosmetic Surgery Market by Procedure Type

Non-surgical Cosmetic Procedures hold the largest share of the North America Cosmetic Surgery Market with a market share of 58.0% in 2025. This procedures include botulinum toxin injections, dermal fillers, chemical peeling, laser skin resurfacing, non-invasive skin tightening, non-invasive fat reduction, microdermabrasion, and various other forms of cosmetic treatment that do not require surgical intervention.

This market segment will be driven by increasing demand for therapies with minimal downtime, reduced risks of procedure and quick results. The increasing patient preference for minimally invasive cosmetic surgeries for facial rejuvenation, treatment of wrinkles, lip augmentation, skin tightening, body contouring, and skin texture improvement are key areas within this market.

As per ISAPS, in 2024, more than 20.5 million nonsurgical treatments have been carried out around the world, which was higher than the number of surgeries carried out for aesthetic purposes by the plastic surgeons. In the U.S., the demand for nonsurgical treatments is still quite high. As per the American Society of Plastic Surgeons (ASPS), in 2024, hyaluronic acid fillers were one of the top minimally invasive treatments, with 5,331,426 procedures performed. Out of these procedures, 1,589,502 procedures were related to lip augmentation, whereas 932,861 procedures involved non-hyaluronic acid fillers like Radiesse, Sculptra, Bellafill.

Whereas surgeries such as liposuction, breast augmentation, nose reshaping, and tummy tuck remain highly sought after, non-surgical procedures are easier and can be done repeatedly. For this reason, non-surgical procedures become the most popular procedure type in the North America Cosmetic Surgery Market.

United States Leads the North America Cosmetic Surgery Market by Country

The United States leads the way among all countries in the North America cosmetic surgery market with a share of 82.0% of the market in 2025. Dominance of the United States is attributed to high volumes of aesthetic procedures, powerful consumer spending capabilities, availability of highly advanced cosmetic surgery clinics, and early acceptance of innovative injectable and energy-based devices.

There is an advanced aesthetic care system in place in the U.S., with plastic surgeons, dermatologists, medical spas, cosmetic centers, and device-based therapy providers being some of them. There is also a high degree of availability of products including botulinum toxins, dermal fillers, breast implants, laser, radiofrequency, and ultrasound skin-tightening technologies.

The United States carried out the greatest number of aesthetic/cosmetic procedures in the world in 2024, at over 6.1 million procedures according to ISAPS. The ASPS revealed that liposuction was the most popular cosmetic surgical procedure in the country in 2023, with 347,782 procedures carried out, while there were 304,181 breast augmentations.

This market is additionally bolstered owing to strong brand presence from companies like Allergan Aesthetics, Galderma, Merz Aesthetics, Solta Medical, InMode, Cutera, Cynosure, Candela, and Mentor Worldwide. Presence of professional aestheticians, higher awareness, and greater demand for non-invasive facial aesthetics will assist in retaining the dominance of the United States through the forecast period.

Analysis of Key Players in the North America Cosmetic Surgery Market

AbbVie Inc., Galderma Group AG, Merz Pharma GmbH & Co. KGaA, Bausch Health Companies Inc., InMode Ltd., Cutera, Inc., Cynosure Lutronic, Inc., Candela Corporation, Sisram Medical Ltd., Johnson & Johnson Services, Inc., Establishment Labs Holdings Inc., Evolus, Inc., Crown Laboratories, Inc., Tiger Aesthetics Medical, LLC, Hologic, Inc., Sinclair Pharma Limited, Fotona d.o.o., El.En. S.p.A., Venus Concept Inc., Sciton, Inc. and others are some of the leading companies operating in the North America Cosmetic Surgery market.

Each of these companies has been profiled in the North America Cosmetic Surgery market report based on parameters such as company overview, business strategies, financial overview, business segments, product portfolio, service portfolio, and recent developments.

Key Developments in the North America Cosmetic Surgery Market

• In January 2026, Allergan Aesthetics, an AbbVie company, announced new data across its facial injectables portfolio at the 2026 International Master Course on Aging Science World Congress. The company stated that the data covered on-market and emerging facial injectables, including botulinum neurotoxin and hyaluronic acid-based filler products.
• In April 2026, Merz Aesthetics received U.S. FDA approval for RADIESSE for the treatment of wrinkles in the décolleté area in patients aged 22 years and older. The company stated that RADIESSE became the first and only regenerative biostimulator approved in the U.S. for the face and body.
• In February 2026, Bausch Health Companies Inc. and Solta Medical announced the launch of the Clear + Brilliant Touch laser in Canada. The device was approved by Health Canada in May 2025 and became available in Canada to support demand for non-invasive skin rejuvenation treatments.

North America Cosmetic Surgery Market Snapshot